Antimalarial drugs for children

Medicines for children

Children are not just little adults. Medicines are absorbed and metabolized differently in children and should be adapted for their weight and age. MMV is working hard to ensure that antimalarial medicines appropriate for children remain available, while bringing forward new formulations.

MMV and partners have developed several child-friendly formulations (see them below). In addition, MMV is working with other organizations as part of the PAMAfrica consortium to develop the first malaria treatment for children under 5kg.

Coartem® Dispersible

A child-friendly formulation developed with Novartis for treatment of uncomplicated malaria.

Larinate® 60mg

Ipca's injectable artesunate product for treatment of severe malaria.

Artesun®

Fosun Pharma's injectable artesunate product for treatment of severe malaria.

Tafenoquine paediatric

A single-dose product for prevention of relapse in children, developed with GSK.

Supyra®

S Kant's product for seasonal malaria chemoprevention

SPAQ-CO™

Fosun Pharma's prpoduct for seasonal malaria chemoprevention in children.

Artecap™

Strides Pharma's severe malaria pre-referral intervention for children.

Artesunate rectocaps

Cipla's severe malaria pre-referral intervention for children.

Pyramax® granules

Shin Poong's product for treatment of uncomplicated malaria in children.

Wiwal®

Universal Corporation's product for malaria prevention in pregnant women and infants.